Literature DB >> 23806154

Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies.

Vincenzo Ruocco1, Eleonora Ruocco2, Ada Lo Schiavo2, Giampiero Brunetti2, Luigi Pio Guerrera2, Ronni Wolf3.   

Abstract

Pemphigus includes a group of autoimmune bullous diseases with intraepithelial lesions involving the skin and Malpighian mucous membranes. Pemphigus vulgaris (PV), the most frequent and representative form of the group, is a prototypical organ-specific human autoimmune disorder with a poor prognosis in the absence of medical treatment. The pathomechanism of PV hinges on autoantibodies damaging cell-cell cohesion and leading to cell-cell detachment (acantholysis) of the epidermis and Malpighian mucosae (mainly oral mucosa). A controversy exists about which subset of autoantibodies is primarily pathogenic: the desmoglein-reactive antibodies or those directed against the acetylcholine receptors of the keratinocyte membrane. The onset and course of PV depend on a variable interaction between predisposing and inducing factors. Genetic predisposition has a complex polygenic basis, involving multiple genetic loci; however, the genetic background alone ("the soil"), although essential, is not by itself sufficient to initiate the autoimmune mechanism, as proven by the reports of PV in only one of two monozygotic twins and in only two of three siblings with an identical PV-prone haplotype. The intervention of inducing or triggering environmental factors ("the seed") seems to be crucial to set off the disease. The precipitating factors are many and various, most of them directly originating from the environment (eg, drug intake, viral infections, physical agents, contact allergens, diet), others being endogenous (eg, emotional stress, hormonal disorders) but somehow linked with the subject's lifestyle. As to certain drugs, their potential of provoking acantholysis may be implemented by their interfering with the keratinocyte membrane biochemistry (biochemical acantholysis) and/or with the immune balance (immunologic acantholysis). Viral infections, especially the herpetic ones, may trigger the outbreak of PV or simply complicate its clinical course. The precipitating effect might be due to interferons and other cytokines released by the host as a consequence of the viral attack, which overactivate the immune response. Inductions of PV by physical agents (ultraviolet or ionizing radiation, thermal or electrical burns, surgery and cosmetic procedures), contact allergens (in particular, organophosphate pesticides), dietary factors (eg, garlic, leek, onion, black pepper, red chili pepper, red wine, tea), and emotional stress are rare, but well-documented events. The possible intervention of the environment in the outbreak of PV has been overlooked in the past, but nowadays clinicians perceive it more frequently. The assumption that genetic factors alone are not sufficient to cause the outbreak of the disease, inevitably instills the idea that PV may not occur spontaneously, but always results from an interaction between an individual predisposing genetic background and environmental precipitating factors, often concealed or apparently harmless.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23806154     DOI: 10.1016/j.clindermatol.2013.01.004

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  28 in total

Review 1.  Pemphigus.

Authors:  Michael Kasperkiewicz; Christoph T Ellebrecht; Hayato Takahashi; Jun Yamagami; Detlef Zillikens; Aimee S Payne; Masayuki Amagai
Journal:  Nat Rev Dis Primers       Date:  2017-05-11       Impact factor: 52.329

Review 2.  Desmosomes in acquired disease.

Authors:  Sara N Stahley; Andrew P Kowalczyk
Journal:  Cell Tissue Res       Date:  2015-03-21       Impact factor: 5.249

3.  The role of oral microbiome in pemphigus vulgaris.

Authors:  Matina Zorba; Angeliki Melidou; Aikaterini Patsatsi; Athanasios Poulopoulos; Georgia Gioula; Alexandros Kolokotronis; Fani Minti
Journal:  Arch Microbiol       Date:  2021-02-26       Impact factor: 2.552

4.  Is there an association between pemphigus and hepatitis viruses? A population-based large-scale study.

Authors:  Khalaf Kridin; Shira Zelber-Sagi; Doron Comaneshter; Arnon D Cohen
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

5.  [Cutaneous drug reactions imitating dermatoses].

Authors:  N Magnolo; T Schwarz; S Ständer
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

6.  Spatial Distribution of Pemphigus Occurrence over Five Decades in Southeastern Brazil.

Authors:  Beatriz Smidt Celere; Sebastian Vernal; Leonardo La Serra; Maria José Franco Brochado; Luiz Eduardo Moschini; Ana Maria Roselino; Susana Inés Segura-Muñoz
Journal:  Am J Trop Med Hyg       Date:  2017-09-21       Impact factor: 2.345

7.  Successful treatment of pemphigus vulgaris with the extensive mucocutaneous lesions in an elderly patient.

Authors:  Mohsen Masjedi; Ali Asilian; Zabihollah Shahmoradi; Parvin Rajabi Dehnavi; Bahareh Abtahi Naeini
Journal:  Iran Red Crescent Med J       Date:  2014-06-05       Impact factor: 0.611

Review 8.  Epidermal multinucleated giant cells are not always a histopathologic clue to a herpes virus infection: multinucleated epithelial giant cells in the epidermis of lesional skin biopsies from patients with acantholytic dermatoses can histologically mimic a herpes virus infection.

Authors:  Philip R Cohen; Taraneh Paravar; Robert A Lee
Journal:  Dermatol Pract Concept       Date:  2014-10-31

9.  The value of trichoscopy in the differential diagnosis of scalp lesions in pemphigus vulgaris and pemphigus foliaceus.

Authors:  Marta Sar-Pomian; Marta Kurzeja; Lidia Rudnicka; Malgorzata Olszewska
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

10.  Pemphigus erythematosus relapse associated with atorvastatin intake.

Authors:  Ada Lo Schiavo; Rosa Valentina Puca; Francesca Romano; Roberto Cozzi
Journal:  Drug Des Devel Ther       Date:  2014-09-18       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.